Olesoxime

Olesoxime Suppliers list
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:Olesoxime (TRO-19622)
CAS:22033-87-0
Purity:98% Package:10mg Remarks:V5150
Company Name: LEAP CHEM CO., LTD.
Tel: +86-852-30606658
Email: market18@leapchem.com
Products Intro: Product Name:Olesoxime
CAS:22033-87-0
Package:1g; 5g; 25g; 1kg; 5kg; 25kg
Company Name: Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel: +86-057181025280; +8617767106207
Email: sales@molcore.com
Products Intro: Product Name:Olesoxime
CAS:22033-87-0
Purity:NLT 98% Remarks:MC541591
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:Olesoxime;NSC 21311;TRO 19622
CAS:22033-87-0
Package:1 mL * 10mM (in DMSO);10 mg;100 mg;2 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Shanghai Acmec Biochemical Technology Co., Ltd.
Tel: +undefined18621343501
Email: product@acmec-e.com
Products Intro: Product Name:Olesoxime
CAS:22033-87-0
Purity:99% Package:50mg, 10mg, 5mg
Olesoxime Basic information
Product Name:Olesoxime
Synonyms:(NE)-N-[10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,6,7,8,9,11,12,14,1 5,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]hydroxylamine;olesoxime;Cholest-4-en-3-one, oxime, NSC 21311;TRO 19622;Cholest-4-en-3-one oxime;NSC 21311;TRO19266;OLESOXIME;NSC 21311;TRO19622;TRO-19622
CAS:22033-87-0
MF:C27H45NO
MW:399.65
EINECS:
Product Categories:
Mol File:22033-87-0.mol
Olesoxime Structure
Olesoxime Chemical Properties
Melting point 145-148 ºC
Boiling point 510.0±23.0 °C(Predicted)
density 1.10
storage temp. -20°C
solubility DMSO: >10mg/mL
pka12.27±0.70(Predicted)
form solid
color white
Stability:Stable for 1 year as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
CAS DataBase Reference22033-87-0(CAS DataBase Reference)
Safety Information
WGK Germany 3
MSDS Information
Olesoxime Usage And Synthesis
DescriptionTRO19622 (22033-87-0) is a neuroregenerative and neuroprotective agent acting at components of the mitochondrial permeability transition pore (MPTP).1?Rescues motor neurons from axotomy-induced cell death and promotes nerve regeneration following sciatic nerve crush in mice. Reduces ROS and NLRP3 inflammasome activation in a mouse model of intracerebral hemorrhage.2?Inhibits MPTP opening and protects neurons from apoptosis.3?Induces oligodendrocyte maturation in culture and promotes myelin regeneration?in vivo?in a rodent model.4
UsesTRO 19622 interacts with mitochondria proteins and is able to promote neuron survival under stress conditions. It is a potential drug for treating amyotrophic lateral sclerosis (ALS). TRO 19622 is a neuroregenerative and neuroprotective agent. This is a research product for neuroscience.
UsesTRO 19622 has been used as a mitochondrial permeability transition pore inhibitor in mouse neurons2. TRO 19622 is also known to stimulate myelin repair in rat models of demyelination3.
Biological ActivityNeuroprotective and neuroregenerative compound. Rescues motor neurons from axotomy-induced cell death and promotes nerve regeneration following sciatic nerve crush in vivo . Binds directly to two components of the mitochondrial permeability pore, the voltage-dependent anion channel (VDAC) and translocator protein.
Biochem/physiol ActionsTRO 19622 can decrease axonal degradation and enhance the rescue of motor nerve conduction in peripheral neuropathy. Furthermore, TRO 19622 can reverse neuropathic pain and tactile allodynia in rat models of diabetes and chemotherapy-induced neuropathic pain4.
storageDesiccate at +4°C
References1) Bordet?et al.?(2007),?Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis; J. Pharmacol. Exp. Ther.,?322?709 2) Ma?et al.?(2014),?NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage; Ann. Neurol.,?75?209 3) Martin?et al.?(2011),?The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation; J. Neurosci.,?31?359 4) Magalon?et al. (2016),?Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules; Neuropharmacology,?111?293
Olesoxime Preparation Products And Raw materials
Tag:Olesoxime(22033-87-0) Related Product Information
Simvastatin (1R,4aS,10aR)-1,2,3,4,4a,9,10,10a-Octahydro-1-,4a-dimethyl-7-(1-methylethyl)-1-phenanthrenemethanamine hydrochloride Lovastatin antibiotic 1233A Orlistat Dimethylglyoxime Androstenedione 4-Cholesten-3-one Clethodim 6-Methyl-5-hepten-2-one Zearalenone Trenbolone Quinocetone OXIME Olesoxime CHOLEST-4-ENE